Clinical Trial Update: Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method [Phase 3]

View source ↗

Summary

Phase 3 follow-up open-label study of levetiracetam for partial-onset seizures in epilepsy; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Japan Co. Ltd. | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED | Results posted: 2019-06-10